Skip to content
ClinCalc Pro
Menu
Oral iron + vitamin C

Ferrous sulfate with ascorbic acid

Brand names: Ferrograd C

Used in: Anaemia

This fixed combination of ferrous sulfate with ascorbic acid (vitamin C) is an oral preparation for treating and preventing iron-deficiency anaemia.

Dosing — being independently re-sourced

ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.

Clinical monograph

How it works

Ferrous sulfate provides absorbable iron[II] for haemoglobin synthesis, while ascorbic acid acts as a reducing agent that helps keep iron in the ferrous state and may modestly enhance its intestinal absorption.

Prescribing in practice

  • As with all iron products, accidental overdose is dangerous and potentially fatal in children, so secure storage out of reach is the priority safety point.
  • The same absorption interactions apply as for plain ferrous sulfate, requiring separation from tea, antacids, calcium and chelated drugs such as quinolones, tetracyclines and levothyroxine.
  • The added ascorbic acid offers only a modest absorption benefit and does not reduce the gastrointestinal side effects typical of oral iron.

Monitoring

Reassess haemoglobin and iron indices after several weeks, continuing treatment beyond normalisation to replenish stores.

Counselling the patient

  • Black stools are normal with this iron-containing product.
  • Keep away from children because of the risk of serious overdose.
  • Avoid taking with tea, milk or indigestion remedies at the same time.

Evidence & guidelines

Oral ferrous salts are first-line for iron-deficiency anaemia per NICE; the contribution of added vitamin C to absorption in practice is generally regarded as small.

Reference: Confirm identity and dosing against the manufacturer SPC (eMC) and NICE. Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).

Related

Curated clinical cross-links plus same-class fallbacks.